Observational Study of Hydroxychloroquine in Hospitalized Patients with COVID-19
Geleris, J., Sun, Y., Platt, J., Zucker, J., Baldwin, M., Hripcsak, G., Labella, A., Manson, D., Kubin, C., Barr, R., Sobieszczyk, M., & Schluger, N. ((2020). Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19. The New England Journal of Medicine. DOI: 10.1056/NEJMoa2012410 https://www.nejm.org/doi/full/10.1056/nejmoa2012410
0
1
Contributors are:
Who are from:
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
Hydroxychloroquine for the Prevention of Covid-19 — Searching for Evidence
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
Observational Study of Hydroxychloroquine in Hospitalized Patients with COVID-19
Universal Screening for SARS-CoV-2 in Women Admitted for Delivery
COVID-19 in Critically Ill Patients in the Seattle Region -Case Series
Observational Study of Hydroxychloroquine in Hospitalized Patients with COVID-19
Compassionate Use of Remdesivir for Patients with Severe COVID-19
Hydroxychloroquine with or without azithromycin in mild-to-moderate COVID-19
Observational Study of Hydroxychloroquine in Hospitalized Patients with COVID-19
Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2